Sami Sayadi Selected Research

3,4-dihydroxyphenylethanol (hydroxytyrosol)

1/2022	Protective effect of olive leaves phenolic compounds against neurodegenerative disorders: Promising alternative for Alzheimer and Parkinson diseases modulation.
1/2020	Comparative Study on Beneficial Effects of Hydroxytyrosol- and Oleuropein-Rich Olive Leaf Extracts on High-Fat Diet-Induced Lipid Metabolism Disturbance and Liver Injury in Rats.
7/2018	Oleuropein and hydroxytyrosol protect rats' pups against bisphenol A induced hypothyroidism.
6/2018	Oleuropein and hydroxytyrosol rich extracts from olive leaves attenuate liver injury and lipid metabolism disturbance in bisphenol A-treated rats.
1/2015	The α-Glucosidase and α-Amylase Enzyme Inhibitory of Hydroxytyrosol and Oleuropein.
1/2011	Hydroxytyrosol rich extract from olive leaves modulates cell cycle progression in MCF-7 human breast cancer cells.
10/2009	Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats.
4/2008	Lipid-lowering and antioxidant effects of hydroxytyrosol and its triacetylated derivative recovered from olive tree leaves in cholesterol-fed rats.
2/2007	Hypocholesterolemic effects of phenolic extracts and purified hydroxytyrosol recovered from olive mill wastewater in rats fed a cholesterol-rich diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sami Sayadi Research Topics

Disease

8	Body Weight (Weight, Body) 01/2020 - 02/2007
6	Neoplasms (Cancer) 04/2018 - 10/2008
4	Hypercholesterolemia 10/2009 - 09/2005
3	Inflammation (Inflammations) 09/2022 - 08/2017
3	Obesity 01/2022 - 07/2015
2	Hyperlipidemias (Hyperlipidemia) 06/2018 - 11/2008
2	Starvation 07/2015 - 06/2014
2	Hyperglycemia 01/2015 - 10/2009
1	Wounds and Injuries (Trauma) 02/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Hypothyroidism 07/2018
1	Insulin Resistance 04/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014
1	Leukemia 01/2014
1	Cross Infection (Nosocomial Infection) 03/2012
1	Hypertension (High Blood Pressure) 01/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Atherosclerosis 01/2011
1	Carcinogenesis 01/2011
1	Necrosis 07/2010
1	Cysts 01/2009

Drug/Important Bio-Agent (IBA)

9	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 01/2022 - 02/2007
8	AntioxidantsIBA 09/2022 - 10/2008
7	oleuropeinIBA 01/2020 - 10/2009
5	CholesterolIBA 05/2016 - 09/2005
4	LipidsIBA 01/2020 - 06/2014
4	LDL CholesterolIBA 11/2008 - 09/2005
4	oxidized low density lipoproteinIBA 11/2008 - 09/2005
3	FlavonoidsIBA 02/2022 - 04/2018
3	EnzymesIBA 01/2020 - 10/2009
3	Triglycerides (Triacylglycerol)IBA 05/2016 - 04/2008
3	Biological ProductsIBA 04/2016 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2020
2	bisphenol AIBA 07/2018 - 06/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2016 - 04/2016
2	Therapeutic UsesIBA 01/2014 - 01/2011
2	Volatile Oils (Essential Oils)IBA 06/2012 - 03/2012
2	Glucose (Dextrose)FDA LinkGeneric 06/2012 - 10/2009
2	HDL CholesterolIBA 04/2008 - 02/2007
1	myricetin-3-O-rhamnosideIBA 02/2022
1	CollagenIBA 02/2022
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2022
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022
1	PhenolsIBA 01/2022
1	apigetrinIBA 04/2018
1	decamethrin (deltamethrin)IBA 08/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2016
1	AdiponectinIBA 05/2016
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2016
1	Insulin (Novolin)FDA Link 04/2016
1	PhytochemicalsIBA 07/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2015
1	Lipase (Acid Lipase)FDA Link 07/2015
1	Antihypertensive Agents (Antihypertensives)IBA 07/2015
1	cinnamic acidIBA 07/2015
1	Phosphorus (Red Phosphorus)IBA 07/2015
1	GlucosidasesIBA 01/2015
1	sodium carbonate FDA LinkGeneric 06/2014
1	Phosphates (Orthophosphate)IBA 06/2014
1	olive leaf extractIBA 01/2014
1	Thiobarbituric Acid Reactive SubstancesIBA 06/2012
1	Liver GlycogenIBA 06/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	Neutral RedIBA 01/2011
1	Food Additives (Food Additive)IBA 01/2011
1	WastewaterIBA 07/2010

Therapy/Procedure

2	Oral Administration 01/2020 - 06/2018
1	Therapeutics 01/2014
1	Bioreactors (Bioreactor) 01/2009